Who Owns Niagen Bioscience Stock?
NASDAQ: NAGEHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 41.53%
- Held by insiders
- 29.45%
- Institutional holders
- 187
- Institutions 41.5%
- Insiders 29.5%
- Public and other 29.0%
Who owns Niagen Bioscience stock?
Institutional investors own about 41.5% of Niagen Bioscience's shares, spread across 187 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 29.45% of NAGE.
The largest institutional holders are Blackrock Inc. (5.25%), SteelPeak Wealth, LLC (4.39%) and Vanguard Capital Management LLC (2.70%). Together, the top 10 institutions control 24.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their NAGE positions and 6 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NAGE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 4.18M | 5.25% | +8.1% |
| SteelPeak Wealth, LLC | 3.50M | 4.39% | +3.8% |
| Vanguard Capital Management LLC | 2.15M | 2.70% | -0.1% |
| Tieton Capital Management, LLC | 2.01M | 2.52% | -1.0% |
| Qube Research & Technologies Ltd | 1.63M | 2.04% | -5.2% |
| Geode Capital Management, LLC | 1.48M | 1.86% | +9.9% |
| UBS Group AG | 1.28M | 1.61% | -8.7% |
| Goldman Sachs Group Inc | 1.26M | 1.59% | +0.9% |
| Arrowstreet Capital, Limited Partnership | 1.17M | 1.47% | -50.8% |
| Vanguard Portfolio Management LLC | 1.17M | 1.46% | -4.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NAGE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.47M | 1.85% |
| iShares Trust-iShares Russell 2000 ETF | 1.47M | 1.84% |
| VANGUARD WORLD FUND-Vanguard Consumer Staples Index Fund | 655.47K | 0.82% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 629.41K | 0.79% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 625.76K | 0.79% |
| iShares Trust-iShares Russell 2000 Growth ETF | 547.64K | 0.69% |
| Victory Portfolios III-Victory Small Cap Stock Fund | 282.65K | 0.35% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 274.60K | 0.34% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 272.00K | 0.34% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 265.99K | 0.33% |
Frequently asked questions
Who is the largest shareholder of Niagen Bioscience?
Blackrock Inc. is the largest institutional shareholder of NAGE, owning 5.25% of shares outstanding (4.18M shares) as of its latest 13F filing.
What percentage of Niagen Bioscience is owned by institutions?
Institutions own about 41.5% of NAGE shares and 58.9% of the public float.
How much of Niagen Bioscience do insiders own?
Insiders, such as officers and directors, own about 29.45% of NAGE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.